Inventor · disambiguated record
Benjamin Alexander Mayes
Also filed as: MAYES BENJAMIN · MAYES BENJAMIN A · MAYES BENJAMIN ALEXANDER
17 granted patents·14 pending applications·325 citations·filing 2006–2018
93Inventor score
Files withIDENIX PHARMACEUTICALS INC15IDENIX PHARMACEUTICALS LLC12CENTRE NAT RECH SCIENT1MERCK SHARP & DOHME1MOUSSA ADEL1
Top patents by PatentIndex Score
31 records- 0198US9211300B24′-fluoro nucleosides for the treatment of HCVIDENIX PHARMACEUTICALS INC·Filed 2013·Granted Dec 15, 2015·66 cites·23 claims
- 0297US9187515B22′,4′-fluoro nucleosides for the treatment of HCVIDENIX PHARMACEUTICALS INC·Filed 2014·Granted Nov 17, 2015·51 cites·16 claims
- 0396US9309275B23′-deoxy nucleosides for the treatment of HCVIDENIX PHARMACEUTICALS INC·Filed 2014·Granted Apr 12, 2016·28 cites·24 claims
- 0496US9192621B2Esters and malonates of SATE prodrugsIDENIX PHARMACEUTICALS LLC·Filed 2013·Granted Nov 24, 2015·32 cites·22 claims
- 0596US9109001B23′,5′-cyclic phosphoramidate prodrugs for HCV infectionIDENIX PHARMACEUTICALS INC·Filed 2013·Granted Aug 18, 2015·60 cites·28 claims
- 0693US9339541B2Thiophosphate nucleosides for the treatment of HCVIDENIX PHARMACEUTICALS INC·Filed 2014·Granted May 17, 2016·36 cites·20 claims
- 0791US7781576B2Process for preparing a synthetic intermediate for preparation of branched nucleosidesIDENIX PHARMACEUTICALS INC·Filed 2006·Granted Aug 24, 2010·29 cites·38 claims
- 0883US8093379B2Macrocyclic serine protease inhibitorsMOUSSA ADEL·Filed 2009·Granted Jan 10, 2012·16 cites·18 claims
- 0979US7960428B2Enantiomerically pure phosphoindoles as HIV inhibitorsIDENIX PHARMACEUTICALS INC·Filed 2007·Granted Jun 14, 2011·3 cites·42 claims
- 1077US10251903B2Process for making nucleoside phosphoramidate compoundsMERCK SHARP & DOHME·Filed 2015·Granted Apr 9, 2019·2 cites·8 claims
- 1173US10683321B24′-or nucleosides for the treatment of HCVIDENIX PHARMACEUTICALS LLC·Filed 2014·Granted Jun 16, 2020·2 cites·17 claims
- 1269US10717758B2D-amino acid compounds for liver diseaseIDENIX PHARMACEUTICALS LLC·Filed 2018·Granted Jul 21, 2020·0 cites·24 claims
- 1364US2015037282A1D-amino acid phosphoramidate pronucleotides of halogeno pyrimidine compounds for liver diseaseIDENIX PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 1456US10513534B22′-chloro nucleoside analogs for HCV infectionIDENIX PHARMACEUTICALS LLC·Filed 2013·Granted Dec 24, 2019·0 cites·60 claims
- 1556US10238680B2D-amino acid phosphoramidate pronucleotides of halogeno pyrimidine compounds for liver diseaseIDENIX PHARMACEUTICALS LLC·Filed 2015·Granted Mar 26, 2019·0 cites·21 claims
- 1656US2016280729A1Cyclopentane and cyclopentene nucleoside analogs for the treatment of hcvIDENIX PHARMACEUTICALS LLC·Filed 2014·Application pending·0 cites
- 1756US2013315868A1D-amino acid compounds for liver diseaseIDENIX PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 1852US10231986B2Amino acid phosphoramidate pronucleotides of 2′-cyano, azido and amino nucleosides for the treatment of HCVCENTRE NAT RECH SCIENT·Filed 2015·Granted Mar 19, 2019·0 cites·31 claims
- 1952US2014140952A1D-Alanine Ester of Sp-Nucleoside AnalogIDENIX PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 2050US8486991B2Enantiomerically pure phosphoindoles as HIV inhibitorsSTORER RICHARD·Filed 2011·Granted Jul 16, 2013·0 cites·22 claims
- 2147US2016002281A1D-amino acid compounds for liver diseaseIDENIX PHARMACEUTICALS LLC·Filed 2015·Application pending·0 cites
- 2246US10723754B22′,4′-bridged nucleosides for HCV infectionIDENIX PHARMACEUTICALS LLC·Filed 2013·Granted Jul 28, 2020·0 cites·16 claims
- 2346US2016271162A1D-alanine phosphoramide pronucleotides of 2'-methyl 2'-fluro guanosine nucleoside compounds for the treatment of hcvIDENIX PHARMACEUTICALS LLC·Filed 2014·Application pending·0 cites
- 2444US2014140951A1D-Alanine Ester of Rp-Nucleoside AnalogIDENIX PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 2542US2016083413A12'-chloro nucleoside analogs for hcv infectionIDENIX PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
- 2641US2013217644A1Pharmaceutical Compositions of 2'-C-Methyl-Guanosine, 5'-[2[(3-Hydroxy-2,2-Dimethyl-1-Oxopropyl)Thio]Ethyl N-(Phenylmethyl)Phosphoramidate]IDENIX PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 2741US2017135990A1Pharmaceutical compositions comprising a 5,5-fused heteroarylene flaviviridae inhibitor and their use for treating or preventing flaviviridae infectionIDENIX PHARMACEUTICALS LLC·Filed 2015·Application pending·0 cites
- 2839US2014112886A1Dinucleotide compounds for hcv infectionIDENIX PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 2939US2015224085A1Method of administering a 5,5-fused heteroarylene hepatitis c virus inhibitor for treating of preventing hepatitis c virus infectionIDENIX PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 3034US2017066779A1Solid forms of a flaviviridae virus inhibitor compound and salts thereofIDENIX PHARMACEUTICALS LLC·Filed 2015·Application pending·0 cites
- 3130US2017066795A1Solid prodrug forms of 2'-chloro-2'-methyl uridine for hcvIDENIX PHARMACEUTICALS LLC·Filed 2015·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →